Generative AI has made pharma teams faster, but real value depends on redesigning commercialization workflows, especially as ...
A CMS final rule codifies Medicare drug price negotiation from 2029, adds a fixed combination drug policy and implements a small biotech price floor.
Nuvera’s PURE Engagement research, built on feedback from more than 2,300 physicians and support staff, ranks 2026 patient ...
Specialty distribution and provider platforms drove September-quarter profit gains at the Big Three as brand pricing weighed ...
Siloed pricing, contracting and affordability decisions can undercut a launch. IQVIA experts explain how system-level ...
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean ...
ELPRO CEO Frederik Dresen explains how cold chain monitoring moved from compliance to risk management, and what biologics and advanced therapies demand. The pharmaceutical cold chain has evolved from ...
Emerging biotechs and large pharma companies start a launch from different positions. Jon Hamrick, partner at Curatio Advisors, explains how his firm profiles each therapy against a set of product ...
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management ...
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for ...
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
Octapharma USA's Kerem Tokel, a LogiPharma USA 2026 freight security panelist, discusses theft hotspots, the export of stolen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results